Article may be outdated

This article is 3 days old. Some details may have changed since publication.

Targeted Onc·3 min read·medium

Expanding the Evidence on Lung Cancer Prevention

S
Sai Yendamuri, MD, MBA, FACS
Expanding the Evidence on Lung Cancer Prevention
✦AI Summary

Researchers are investigating whether interventions like metformin, exercise, and GLP-1 receptor agonists can mitigate the effects of obesity on lung cancer development. Clinical trials are being proposed to validate findings from preclinical animal studies in human populations.

Why it matters

Identifying effective interventions for obesity-related cancer could significantly improve prevention strategies and patient outcomes across various cancer types.

✦Dive DeeperCreate a free account to unlock

In an interview with Targeted Onc™, Sai Yendamuri, MD, MBA, FACS, discusses emerging research investigating whether interventions targeting obesity can reverse its effects on lung cancer development and progression. He highlights a recently completed clinical trial evaluating metformin, a commonly used medication, to determine whether it can counteract the adverse effects of obesity. Researchers are currently analyzing the data, with results expected by the end of the year.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in